Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Gastrointestinal Infection Molecular Diagnostics Market: By Technology, By Pathogen Type, By End-User, and Geography
Gastrointestinal Infection Molecular Diagnostics Market: By Technology, By Pathogen Type, By End-User, and Geography
Gastrointestinal Infection Molecular Diagnostics Market size was valued at US$ $ 5,257.8 million in 2023 Projected to reach $ 7,497.5 million by 2030, and is poised to grow at CAGR of 5.2% from 2024-2030. This market encompasses advanced diagnostic technologies used to detect and identify pathogens causing gastrointestinal infections, including bacteria, viruses, and parasites. These molecular diagnostic methods offer rapid, highly sensitive, and specific results, crucial for effective treatment and disease management. The market's growth is driven by factors such as the increasing global burden of gastrointestinal infections, advancements in molecular diagnostic technologies, rising awareness about the importance of early and accurate diagnosis, and the growing demand for point-of-care testing.
For instance, the World Health Organization reports that diarrheal diseases are the second leading cause of death in children under five years old, causing approximately 525,000 deaths annually. This statistic highlights the critical need for accurate and timely diagnostics. Additionally, the rise in antibiotic-resistant pathogens has emphasized the importance of precise pathogen identification for targeted therapy. However, challenges such as the high costs of molecular diagnostic tests, lack of skilled professionals in developing regions, and issues related to reimbursement policies may hinder market growth to some extent.
Study Period
2024-2030Base Year
2023CAGR
5.2%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The market is witnessing a paradigm shift towards multiplex PCR assays that can simultaneously detect multiple gastrointestinal pathogens, improving diagnostic efficiency and reducing time-to-result. This trend aligns with the healthcare sector's push for rapid diagnostics and personalized medicine. There's also a growing focus on developing automated, sample-to-answer systems that simplify the testing process and minimize the risk of human error, making molecular diagnostics more accessible in various healthcare settings. The integration of next-generation sequencing (NGS) technologies is enabling comprehensive pathogen profiling and antimicrobial resistance detection, contributing to better infection control and antibiotic stewardship programs. Moreover, the COVID-19 pandemic has accelerated the adoption of molecular diagnostic technologies across healthcare settings, which is expected to have a positive spillover effect on the gastrointestinal infection diagnostics market. The increasing prevalence of hospital-acquired infections and the growing emphasis on infection prevention and control measures in healthcare facilities are further propelling market growth. Additionally, government initiatives aimed at reducing the burden of foodborne illnesses and improving public health surveillance systems are creating favorable conditions for market expansion in both developed and developing economies.
Based on regions the gastrointestinal infection molecular diagnostics market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is expected to hold the largest share of the gastrointestinal infection molecular diagnostics market in 2023. This dominance is attributed to the region's advanced healthcare infrastructure, high adoption rates of new technologies, significant investments in research and development, and the presence of major market players. The United States, in particular, has been at the forefront of molecular diagnostic innovation, supported by substantial funding from both public and private sectors. Europe follows closely, driven by stringent regulatory standards for diagnostic accuracy and a strong focus on reducing healthcare-associated infections. Countries like Germany and the UK are leading in the adoption of advanced molecular diagnostic technologies. The Asia-Pacific region is projected to experience the fastest growth, fueled by improving healthcare infrastructure, increasing awareness about the benefits of molecular diagnostics, and the high burden of gastrointestinal diseases in densely populated countries like India and China. Moreover, government initiatives to combat antimicrobial resistance and improve diagnostic capabilities in countries such as Japan and South Korea are expected to further boost market growth in this region.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market CAGR |
5.2% |
|
By Technology |
|
|
By Pathogen Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global gastrointestinal infection molecular diagnostics market size is projected to grow from $5,257.8 million in 2023 to $7,497.5 million by 2030, exhibiting a CAGR of 5.2% in the forecast period.
The global gastrointestinal infection molecular diagnostics market is segmented based on technology, pathogen type, end-user, and geography.
The key players include BioMérieux, Qiagen, Roche Diagnostics, Abbott Laboratories, and Becton, Dickinson and Company, among others.
North America dominates the market share due to its advanced healthcare infrastructure, high adoption rates of new technologies, significant investments in research and development, and the presence of major market players in the region.
The market is driven by the increasing prevalence of gastrointestinal infections, advancements in molecular technologies, growing demand for rapid and accurate diagnostic tools, and rising awareness about the importance of early diagnosis.
| 1.Executive Summary |
| 2.Global Gastrointestinal Infection Molecular Diagnostics Market Introduction |
| 2.1.Global Gastrointestinal Infection Molecular Diagnostics Market - Taxonomy |
| 2.2.Global Gastrointestinal Infection Molecular Diagnostics Market - Definitions |
| 2.2.1.Technology |
| 2.2.2.Pathogen Type |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Gastrointestinal Infection Molecular Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Gastrointestinal Infection Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Gastrointestinal Infection Molecular Diagnostics Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Polymerase Chain Reaction (PCR) |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Microarray |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Sequencing |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Isothermal Amplification |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6.Global Gastrointestinal Infection Molecular Diagnostics Market By Pathogen Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Bacterial Infections |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Viral Infections |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Parasitic Infections |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7.Global Gastrointestinal Infection Molecular Diagnostics Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic Laboratories |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Research Institutes |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Point-of-Care Settings |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Global Gastrointestinal Infection Molecular Diagnostics Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Gastrointestinal Infection Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Polymerase Chain Reaction (PCR) |
| 9.1.2.Microarray |
| 9.1.3.Sequencing |
| 9.1.4.Isothermal Amplification |
| 9.2. Pathogen Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Bacterial Infections |
| 9.2.2.Viral Infections |
| 9.2.3.Parasitic Infections |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Diagnostic Laboratories |
| 9.3.3.Research Institutes |
| 9.3.4.Point-of-Care Settings |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Gastrointestinal Infection Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Polymerase Chain Reaction (PCR) |
| 10.1.2.Microarray |
| 10.1.3.Sequencing |
| 10.1.4.Isothermal Amplification |
| 10.2. Pathogen Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Bacterial Infections |
| 10.2.2.Viral Infections |
| 10.2.3.Parasitic Infections |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Diagnostic Laboratories |
| 10.3.3.Research Institutes |
| 10.3.4.Point-of-Care Settings |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Gastrointestinal Infection Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Polymerase Chain Reaction (PCR) |
| 11.1.2.Microarray |
| 11.1.3.Sequencing |
| 11.1.4.Isothermal Amplification |
| 11.2. Pathogen Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Bacterial Infections |
| 11.2.2.Viral Infections |
| 11.2.3.Parasitic Infections |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Diagnostic Laboratories |
| 11.3.3.Research Institutes |
| 11.3.4.Point-of-Care Settings |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Gastrointestinal Infection Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Polymerase Chain Reaction (PCR) |
| 12.1.2.Microarray |
| 12.1.3.Sequencing |
| 12.1.4.Isothermal Amplification |
| 12.2. Pathogen Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Bacterial Infections |
| 12.2.2.Viral Infections |
| 12.2.3.Parasitic Infections |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Diagnostic Laboratories |
| 12.3.3.Research Institutes |
| 12.3.4.Point-of-Care Settings |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Gastrointestinal Infection Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Technology Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Polymerase Chain Reaction (PCR) |
| 13.1.2.Microarray |
| 13.1.3.Sequencing |
| 13.1.4.Isothermal Amplification |
| 13.2. Pathogen Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Bacterial Infections |
| 13.2.2.Viral Infections |
| 13.2.3.Parasitic Infections |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Diagnostic Laboratories |
| 13.3.3.Research Institutes |
| 13.3.4.Point-of-Care Settings |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.BioMérieux |
| 14.2.2.Qiagen |
| 14.2.3.Roche Diagnostics |
| 14.2.4.Abbott Laboratories |
| 14.2.5.Becton, Dickinson and Company |
| 14.2.6.Luminex Corporation |
| 14.2.7.Hologic, Inc. |
| 14.2.8.Bio-Rad Laboratories |
| 14.2.9.Seegene Inc. |
| 14.2.10.Thermo Fisher Scientific |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.